Показано 0 из 0
Дата |
---|
24.01.2024 |
23.01.2024 |
22.01.2024 |
19.01.2024 |
18.01.2024 |
17.01.2024 |
16.01.2024 |
15.01.2024 |
12.01.2024 |
11.01.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
320.50
|
321.00
|
323.00
|
317.00
|
332.00
|
320.50
|
|
|
686 005 000.00
|
1 664.00
|
322.00
|
322.50
|
326.50
|
321.00
|
326.50
|
322.50
|
|
|
159 505 000.00
|
416.00
|
326.00
|
326.50
|
327.00
|
324.00
|
328.00
|
326.50
|
|
|
166 335 000.00
|
435.00
|
325.00
|
325.50
|
322.00
|
321.50
|
326.00
|
325.50
|
|
|
180 822 000.00
|
469.00
|
321.00
|
322.00
|
316.50
|
316.00
|
323.50
|
321.00
|
|
|
250 658 000.00
|
659.00
|
316.00
|
316.50
|
330.50
|
316.00
|
331.50
|
316.00
|
|
|
611 271 000.00
|
1 596.00
|
330.00
|
330.50
|
335.50
|
330.00
|
336.00
|
330.50
|
|
|
309 892 500.00
|
745.00
|
337.50
|
338.00
|
337.50
|
336.50
|
342.00
|
338.00
|
|
|
233 090 000.00
|
537.00
|
336.00
|
336.50
|
334.50
|
333.00
|
338.50
|
336.00
|
|
|
221 659 500.00
|
543.00
|
334.00
|
335.00
|
328.50
|
327.00
|
335.00
|
334.50
|
|
|
283 905 000.00
|
639.00
|
PharmaEssentia Corporation develops and distributes therapeutic products for treatment in human disease. The Company develops drugs to treat hepatitis, chronic myeloid leukemia (CML), essential thrombocythemia (ET), myeloid fibrosis (MF), polycythemia vera (PV), hepatitis and cancer.